Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients

Anticancer Research

Volumn 23, Issue 2 A, 2003, Pages 953-955

  Friedrich, R E ^a   Hagel, C ^a   Brehme, Z ^a   Kluwe, L ^a   Mautner, V F ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Klinikum Nord   (Germany)

Author keywords

Ki 67; MIB 1; Neurofibromatosis type 1; NF1; Plexiform neurofibroma; Surgery for neurofibromatosis

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; CELL PROLIFERATION; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEAD AND NECK TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SEX RATIO; TUMOR CELL; TUMOR CLASSIFICATION; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CELL DIVISION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEUROFIBROMA; NEUROFIBROMATOSIS 1; SEX CHARACTERISTICS;

EID: 0037524324     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Antinheirno J, Haapasalo H, Seppala M, Sainio M, Carpen O and Jaaskelainen J: Proliferative potential of sporadic and neurofibromatosis 2-associated schwannomas as studied by MIB- 1 (Ki-67) and PCNA labeling. J Neuropathol Exp Neurol 54: 776-782 1995.
2. Badache A and DeVries GH: Neurofibroma-derived Schwann cells overexpress platelet-derived growth factor (PDGF) receptors and are induced to proliferate by PDGF BB. J Cell Physiol 177: 334-42, 1998.
3. Chue JY, O'Connor DM and Danis RK: Neurofibrosarcoma at irradiation site in a patient with neurofibromatosis and Wilms'tumor. Cancer J Clin 31: 333-335, 1981.
4. DeClue JE, Heffelfinger S, Benvenuto G, Ling B, Li S, Rui W, Vass WC, Viskochil D and Ratner N: Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models. J Clin Invest 105: 1233-41, 2000.
5. Ducatman BS and Scheithauer BW: Postirradiation neurofibrosarcoma. Cancer 15: 1028-1033, 1983.
6. Gilbert PM: Burn wound complicated by marked neurofibromatosis. Burns 11: 434-435, 1985.
7. Hoekstra G: Über die familiäre neurofibromatosis mit untersuchungen über die häufigkeit von hereditat und malignität bei der Recklinghausenschen Krankheit. Virchows Arch 237: 79-96, 1922.
8. Huson SM, Harper PS and Compston DAS: Von Recklinghausen Neurofibromatosis: a clinical and population study in South East Wales. Brain 111: 1355-81, 1988.
9. Jamjoom AB, Malabarey T, Jamjoom ZA, al-Sohaibani M, Hulailah A and Kolawole T: Cerebro-vasculopathy and malignancy: catastrophic complications of radiotherapy for optic nerve glioma in a von Recklinghausen neurofibromatosis patient. Neurosurg Rev 19: 47-51, 1996.
10. Khoshyomn S, Maier H, Morimura T, Kitz K and Budka H: Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens. Acta Neuropathol (Berl) 86: 582-589, 1993.
11. Kindblom LG, Ahlen M, Meis-Kindblom JM and Stenman G: Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki-67 in benign and malignant peripheral nerve sheath tumours. Virchows Arch 427: 19-26, 1995.
12. King AA, DeBaun MR, Riccardi VM and Gutmann DH: Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93: 388-92, 2000.
13. Kluwe L, Friedrich RE and Mautner VF: Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Cancer Genet Cytogenet 113: 65-69, 1999.
14. Kourea HP, Cordon-Cardo C, Dudas M, Leung D and Woodruff JM: Expression of p27 (kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27 (kip) in malignant transformation of neurofibromas. Am J Pathol 155: 1885-1891, 1999.
15. Liapis H, Marley EF, Lin Y and Dehner LP: p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children. Pediatr Dev Pathol 2: 377-384, 1999.
16. Lin BT-Y, Weiss LM and Medeiros LJ: Neurofibroma, and cellular neurofibroma, with atypia- A report of 14 tumors. Am J Surg Pathol 21: 1443-49, 1997.
17. Louis DN, Edgerton S, Thor AD and Hedley-Whyte ET: Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol (Berl) 81: 675-679, 1991.
18. Mulliken JB: Plastic surgery in neurofibromatosis. In: Rubenstein AE and Korf BR (eds) "Neurofibromatosis. A Handbook for Patients, Families, and Health-Care Professionals." Thieme, New York, 1990, pp.111-124.
19. National Institutes of Health: Consensus Development Conference Statement. Neurofibromatosis. Arch Neurol 45: 575-8, 1988.
20. Perosio, PM and Brooks JJ: Expression of growth factors and growth factor receptors in soft tissue tumors. Implications for the autocrine hypothesis. Lab Invest 60: 245-53, 1989.
21. Recklinghausen FD von: Ueber die Multiplen Fibrome der Haut und Ihre Beziehung zu den Multiplen Neuromen. A Hirschwald, Berlin, 1882.
22. Riccardi VM The potential role of trauma and mast cells in the pathogenesis of neurofibromas. In: Ishibashi Y, Hori Y (eds) Tuberous Solerosis and Neurofibromatosis: Epidemiology, Pathophysiology, Biology and Management. Amsterdam, Elsevier, 1990, pp. 167-190.
23. Riccardi VM: Neurofibromatosis. Phenotype, Natural History, and Pathogenesis. 2nd edition, The Johns Hopkins University Press, Baltimore and London, 1992, pp. 274-275, 343-345.
24. Viskochil D, Buchberg AM, XU G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA, White R and O'Connell P: Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62: 187-92, 1990.
25. Wallace MR, Marchuk DA, Anderson LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH and Collins FS: Type 1 neurofibromatosis gene: identification of a larger transcript disrupted in three NF1 patients. Science 249: 181-6, 1990.
26. Watanabe T, Oda Y, Tamiya S, Masuda K and Tsuneyoshi M: Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components. J Clin Pathol 54: 631-636, 2001.
27. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R and Weiss R: The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599-608, 1990.